SIRT7 antagonizes human stem cell aging as a heterochromatin stabilizer. Issue 7 (6th June 2020)

• Record Type: Journal Article
• Authors: Bi, Shijia; Liu, Zunpeng; Wu, Zeming; Wang, Zehua; Liu, Xiaoqian; Wang, Si; Ren, Jie; Yao, Yan; Zhang, Weiqi; Song, Moshi; Liu, Guang-Hui; Qu, Jing
• Is Part Of: Protein & cell. Volume 11:Issue 7(2020)
• Page Start: 483
• Page End: 504
• Publication Date: 2020-06-06
• Subjects: SIRT7 -- stem cell -- aging -- LINE1 -- cGAS -- STING; Proteins -- Periodicals; Cells -- Periodicals; Cytology -- Periodicals; 572.6
• DOI: 10.1007/s13238-020-00728-4
• Languages: English
• ISSNs: 1674-800X

Abstract

Abstract: SIRT7, a sirtuin family member implicated in aging and disease, is a regulator of metabolism and stress responses. It remains elusive how human somatic stem cell populations might be impacted by SIRT7. Here, we found that SIRT7 expression declines during human mesenchymal stem cell (hMSC) aging and that SIRT7 deficiency accelerates senescence. Mechanistically, SIRT7 forms a complex with nuclear lamina proteins and heterochromatin proteins, thus maintaining the repressive state of heterochromatin at nuclear periphery. Accordingly, deficiency of SIRT7 results in loss of heterochromatin, de-repression of the LINE1 retrotransposon (LINE1), and activation of innate immune signaling via the cGAS-STING pathway. These aging-associated cellular defects were reversed by overexpression of heterochromatin proteins or treatment with a LINE1 targeted reverse-transcriptase inhibitor. Together, these findings highlight how SIRT7 safeguards chromatin architecture to control innate immune regulation and ensure geroprotection during stem cell aging.